116 related articles for article (PubMed ID: 2832544)
1. Studies on inhibitors of skin-tumor promotion, I. Inhibitory effects of triterpenes from Euptelea polyandra on Epstein-Barr virus activation.
Konoshima T; Takasaki M; Kozuka M; Tokuda H
J Nat Prod; 1987; 50(6):1167-70. PubMed ID: 2832544
[No Abstract] [Full Text] [Related]
2. Studies on inhibitors of skin-tumor promotion. Inhibitory effects of triterpenes from Cochlospermum tinctorium on Epstein-Barr virus activation.
Diallo B; Vanhaelen M; Vanhaelen-Fastré R; Konoshima T; Kozuka M; Tokuda H
J Nat Prod; 1989; 52(4):879-81. PubMed ID: 2553872
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors.
Konoshima T; Takasaki M; Tatsumoto T; Kozuka M; Kasai R; Tanaka O; Nie RL; Tokuda H; Nishino H; Iwashima A
Biol Pharm Bull; 1994 May; 17(5):668-71. PubMed ID: 7920430
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumor. II.
Konoshima T; Takasaki M; Kozuka M; Nagao T; Okabe H; Irino N; Nakasumi T; Tokuda H; Nishino H
Biol Pharm Bull; 1995 Feb; 18(2):284-7. PubMed ID: 7742799
[TBL] [Abstract][Full Text] [Related]
5. Studies on inhibitors of skin tumor promotion, III. Inhibitory effects of isoflavonoids from Wisteria brachybotrys on Epstein-Barr virus activation.
Konoshima T; Okamoto E; Kozuka M; Nishino H; Tokuda H; Tanabe M
J Nat Prod; 1988; 51(6):1266-70. PubMed ID: 2853205
[No Abstract] [Full Text] [Related]
6. Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation.
Inada A; Nakanishi T; Tokuda H; Nishino H; Iwashima A; Sharma OP
Planta Med; 1995 Dec; 61(6):558-9. PubMed ID: 8824951
[TBL] [Abstract][Full Text] [Related]
7. Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L.
Ohigashi H; Takamura H; Koshimizu K; Tokuda H; Ito Y
Cancer Lett; 1986 Feb; 30(2):143-51. PubMed ID: 3006912
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of skin-tumor promotion. VIII. Inhibitory effects of euglobals and their related compounds on Epstein-Barr virus activation. (1).
Takasaki M; Konoshima T; Fujitani K; Yoshida S; Nishimura H; Tokuda H; Nishino H; Iwashima A; Kozuka M
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2737-9. PubMed ID: 1963812
[TBL] [Abstract][Full Text] [Related]
9. [Anti-tumor promoting activities and inhibitory effects on Epstein-Barr virus activation of Shi-un-kou and its constituents].
Konoshima T; Kozuka M; Tokuda H; Tanabe M
Yakugaku Zasshi; 1989 Nov; 109(11):843-6. PubMed ID: 2559188
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor-promoting activities of triterpenoids from ferns. I.
Konoshima T; Takasaki M; Tokuda H; Masuda K; Arai Y; Shiojima K; Ageta H
Biol Pharm Bull; 1996 Jul; 19(7):962-5. PubMed ID: 8839970
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects on Epstein-Barr virus activation of anthraquinones: correlation with redox potentials.
Koyama J; Tagahara K; Osakai T; Tsujino Y; Tsurumi S; Nishino H; Tokuda H
Cancer Lett; 1997 May; 115(2):179-83. PubMed ID: 9149122
[TBL] [Abstract][Full Text] [Related]
12. Studies on the inhibitory effects of some acridone alkaloids on Epstein-Barr virus activation.
Takemura Y; Ju-ichi M; Ito C; Furukawa H; Tokuda H
Planta Med; 1995 Aug; 61(4):366-8. PubMed ID: 7480187
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of quassinoids on Epstein-Barr virus activation.
Okano M; Fukamiya N; Tagahara K; Tokuda H; Iwashima A; Nishino H; Lee KH
Cancer Lett; 1995 Aug; 94(2):139-46. PubMed ID: 7634241
[TBL] [Abstract][Full Text] [Related]
14. Distribution and characterization of environmental promoter substances as assayed by synergistic Epstein-Barr virus-activating system.
Ito Y; Tokuda H; Ohigashi H; Koshimizu K
Princess Takamatsu Symp; 1983; 14():125-37. PubMed ID: 6097577
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation.
Uesato S; Taniuchi K; Kumagai A; Nagaoka Y; Seto R; Hara Y; Tokuda H; Nishino H
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1448-50. PubMed ID: 14646330
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of stabilized analogues of glycoglycerolipids on Epstein-Barr virus activation and mouse skin tumor promotion.
Colombo D; Compostella F; Ronchetti F; Reza-Elahi S; Scala A; Toma L; Aoi W; Kuchide M; Takayasu J; Tokuda H; Nishino H
Cancer Lett; 2002 Dec; 186(1):37-41. PubMed ID: 12183073
[TBL] [Abstract][Full Text] [Related]
17. Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation of poly-substituted anthraquinones.
Koyama J; Morita I; Kobayashi N; Osakai T; Nishino H; Tokuda H
Cancer Lett; 2005 Jul; 225(2):193-8. PubMed ID: 15978323
[TBL] [Abstract][Full Text] [Related]
18. Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation by emodin derivatives.
Koyama J; Inoue M; Morita I; Kobayashi N; Osakai T; Nishino H; Tokuda H
Cancer Lett; 2006 Sep; 241(2):263-7. PubMed ID: 16338070
[TBL] [Abstract][Full Text] [Related]
19. Antitumor-promoting effects of cyclic diarylheptanoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis.
Ishida J; Kozuka M; Wang H; Konoshima T; Tokuda H; Okuda M; Yang Mou X; Nishino H; Sakurai N; Lee KH; Nagai M
Cancer Lett; 2000 Oct; 159(2):135-40. PubMed ID: 10996724
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-activating principle in the ether extracts of soils collected from under plants which contain active diterpene esters.
Ito Y; Ohigashi H; Koshimizu K; Yi Z
Cancer Lett; 1983 Jun; 19(2):113-7. PubMed ID: 6309360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
